FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

38112003: un (valeur de l'attribut)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
615211000077111 un (valeur de l'attribut) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
771016011 One (qualifier value) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
un est un(e) (attribut) modificateur adjectival général false Inferred relationship Some
un est un(e) (attribut) nombre true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Ropinirole (as ropinirole hydrochloride) 4 mg prolonged-release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Ropinirole (as ropinirole hydrochloride) 4 mg prolonged-release oral tablet Count of base of active ingredient False un Inferred relationship Some
Linaclotide 145 microgram oral capsule Count of base of active ingredient False un Inferred relationship Some
Linaclotide 145 microgram oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely glyceryl trinitrate 3 milligram/1 each conventional release buccal tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely glyceryl trinitrate 3 milligram/1 each conventional release buccal tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely pilocarpine hydrochloride 100 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely pilocarpine hydrochloride 100 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Ibuprofen 50 mg chewable tablet Count of base of active ingredient False un Inferred relationship Some
Ibuprofen 50 mg chewable tablet Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely deferasirox 500 milligram/1 each tablet for conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Acetaminophen 80 mg rectal suppository Has presentation strength denominator value False un Inferred relationship Some 1
Acetaminophen 80 mg rectal suppository Count of base of active ingredient False un Inferred relationship Some
Product containing precisely droxidopa 300 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely droxidopa 300 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Aspirin 120 mg rectal suppository Count of base of active ingredient False un Inferred relationship Some
Aspirin 120 mg rectal suppository Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely pentobarbital sodium 200 milligram/1 each conventional release rectal suppository (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely pentobarbital sodium 200 milligram/1 each conventional release rectal suppository (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Dimenhydrinate 50 mg chewable tablet Has presentation strength denominator value False un Inferred relationship Some 1
Dimenhydrinate 50 mg chewable tablet Count of base of active ingredient False un Inferred relationship Some
Memantine hydrochloride 7 mg prolonged-release oral capsule Count of base of active ingredient False un Inferred relationship Some
Memantine hydrochloride 7 mg prolonged-release oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely zileuton 600 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely zileuton 600 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely levetiracetam 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely levetiracetam 500 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely aspirin 200 milligram/1 each conventional release rectal suppository (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely aspirin 200 milligram/1 each conventional release rectal suppository (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Clonidine hydrochloride 100 microgram/mL prolonged-release oral suspension Count of base of active ingredient False un Inferred relationship Some
Clonidine hydrochloride 100 microgram/mL prolonged-release oral suspension Has concentration strength denominator value False un Inferred relationship Some 1
Fenofibric acid 135 mg gastro-resistant oral capsule Count of base of active ingredient False un Inferred relationship Some
Fenofibric acid 135 mg gastro-resistant oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Linaclotide 290 microgram oral capsule Count of base of active ingredient False un Inferred relationship Some
Linaclotide 290 microgram oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Nitroglycerin 5 mg buccal tablet Has presentation strength denominator value False un Inferred relationship Some 1
Nitroglycerin 5 mg buccal tablet Count of base of active ingredient False un Inferred relationship Some
Product containing precisely fentanyl 200 microgram/1 each conventional release buccal film (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely fentanyl 200 microgram/1 each conventional release buccal film (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely lansoprazole 15 milligram/1 each gastro-resistant oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely lansoprazole 15 milligram/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely aspirin 650 milligram/1 each gastro-resistant oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely aspirin 650 milligram/1 each gastro-resistant oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Loratadine 5 mg chewable tablet Has presentation strength denominator value False un Inferred relationship Some 1
Loratadine 5 mg chewable tablet Count of base of active ingredient False un Inferred relationship Some
Acetic acid 9.2 mg/g vaginal gel Has concentration strength denominator value False un Inferred relationship Some 1
Acetic acid 9.2 mg/g vaginal gel Count of base of active ingredient False un Inferred relationship Some
Product containing precisely natamycin 50 milligram/1 milliliter conventional release eye suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely natamycin 50 milligram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely ibuprofen 100 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely ibuprofen 100 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely paracetamol 300 milligram/1 each conventional release rectal suppository (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely paracetamol 300 milligram/1 each conventional release rectal suppository (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Metformin hydrochloride 1 g and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
Metformin hydrochloride 1 g and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely naphazoline hydrochloride 300 microgram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely naphazoline hydrochloride 300 microgram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing only droxidopa in oral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely ketorolac trometamol 4.5 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely ketorolac trometamol 4.5 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely fentanyl 600 microgram/1 each conventional release buccal tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely fentanyl 600 microgram/1 each conventional release buccal tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely pemoline 37.5 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely pemoline 37.5 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Fluoxetine (as fluoxetine hydrochloride) 90 mg gastro-resistant oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Fluoxetine (as fluoxetine hydrochloride) 90 mg gastro-resistant oral capsule Count of base of active ingredient False un Inferred relationship Some
Product containing precisely ketorolac trometamol 4 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely ketorolac trometamol 4 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely ascorbic acid 250 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely ascorbic acid 250 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
Besifloxacin 6 mg/mL eye suspension Count of base of active ingredient False un Inferred relationship Some
Besifloxacin 6 mg/mL eye suspension Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely bupropion hydrobromide 174 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely bupropion hydrobromide 174 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Mesalamine 1 g rectal suppository Has presentation strength denominator value False un Inferred relationship Some 1
Mesalamine 1 g rectal suppository Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
Mesalamine 1 g rectal suppository Count of base of active ingredient False un Inferred relationship Some
Product containing precisely paracetamol 325 milligram/1 each conventional release rectal suppository (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely paracetamol 325 milligram/1 each conventional release rectal suppository (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength numerator value (attribute) False un Inferred relationship Some 1
Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely estropipate 1.5 milligram/1 milliliter conventional release vaginal cream (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely estropipate 1.5 milligram/1 milliliter conventional release vaginal cream (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely fentanyl 800 microgram/1 each conventional release buccal tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely fentanyl 800 microgram/1 each conventional release buccal tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Memantine hydrochloride 14 mg prolonged-release oral capsule Count of base of active ingredient False un Inferred relationship Some
Memantine hydrochloride 14 mg prolonged-release oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely deferasirox 125 milligram/1 each tablet for conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Atropine sulfate 5 mg/g eye ointment Has concentration strength denominator value False un Inferred relationship Some 1
Atropine sulfate 5 mg/g eye ointment Count of base of active ingredient False un Inferred relationship Some
Product containing precisely paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely topiramate 25 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely topiramate 25 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely droxidopa 200 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some

Start Previous Page 71 of 217 Next End


This concept is not in any reference sets

Back to Start